Randomized, Open-Label Phase 3 Trial of Nivolumab versus Platinum-Doublet Chemotherapy in Early Stage NSCLC

Sponsor
Bristol Myers Squibb

Protocol Number
Bristol Myers Squibb CA209-816

To Learn More Call
201-510-0910